BackX4 Pharmaceuticals Overview
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Target Price

Analysts' average 12-month price target for X4 Pharmaceuticals is $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.29

Average Target Price

$11.50168.1% upside

2 analysts in the last 4 months

High: $12 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-10Wells Fargo$11156.4% upsideOpen
2026-06-02Leerink PartnersThomas Smith$12179.7% upsideOpen
2026-03-09Guggenheim$12179.7% upsideOpen
2025-12-05Stifel NicolausJames Condulis$10133.1% upsideOpen
2025-11-05Stifel NicolausStephen Willey$7.574.8% upsideOpen
2025-08-29Stifel NicolausStephen Willey$9109.8% upsideOpen
2025-08-13H.C. WainwrightSwayampakula Ramakanth$3.518.4% downsideOpen
2022-12-22Cantor Fitzgerald$330.1% downsideOpen
2022-12-11Piper SandlerEdward Tenthoff$330.1% downsideOpen
2022-11-30H.C. Wainwright$516.6% upsideOpen

X4 Pharmaceuticals (XFOR) FAQ

The latest target price for XFOR is $12. Investors often review this figure alongside X4 Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

X4 Pharmaceuticals trades near $4.29 while the consensus target sits at $12 (168.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting XFOR's target price ($12), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack X4 Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.